Get the Stockscreener App
15.91
0.13%
0.0173
Centessa Pharmaceuticals Plc Adr stock is traded at $15.91, with a volume of 59,080.
It is up +0.13% in the last 24 hours and down -0.19% over the past month.
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.
See More
Previous Close:
$15.89
Open:
$15.77
24h Volume:
59,080
Relative Volume:
0.10
Market Cap:
$2.05B
Revenue:
-
Net Income/Loss:
$-151.09M
P/E Ratio:
-8.7886
EPS:
-1.81
Net Cash Flow:
$-160.51M
1W Performance:
+3.04%
1M Performance:
-0.19%
6M Performance:
+68.00%
1Y Performance:
+116.46%
1-Day Range:
$15.71
$16.07
1-Week Range:
$14.48
$16.07
52-Week Range:
$5.583
$17.59
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile
Name
Centessa Pharmaceuticals Plc Adr
Sector
Industry
Phone
44 7391 789784
Address
3RD FLOOR, ALTRINCHAM, CHESHIRE
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-17-23 | Initiated | SVB Securities | Outperform |
| Aug-12-22 | Downgrade | Morgan Stanley | Overweight → Underweight |
| Jun-17-22 | Initiated | BMO Capital Markets | Outperform |
| Jun-03-22 | Downgrade | Jefferies | Buy → Hold |
| Feb-11-22 | Initiated | Goldman | Neutral |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Latest News
Centessa Pharmaceuticals' chief business officer sells shares for $180,628 - Investing.com
Centessa Pharmaceuticals plcADR (CNTA) Price Target Increased by 14.58% to 11.22 - MSN
Centessa Pharmaceuticals CEO sells shares worth $863,727 - Investing.com
Centessa Pharmaceuticals plc ADR (CNTA) expanding its growth trajectory ahead - SETE News
GSK Plc ADR [GSK] Insider Activity: An Update for Investors - Knox Daily
Centessa Pharmaceuticals plc ADR (CNTA) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
Analysts review Bilibili Inc ADR’s rating - Knox Daily
Centessa Pharmaceuticals plc ADR (CNTA) shows promising results - US Post News
Ratios Uncovered: Breaking Down Centessa Pharmaceuticals plc ADR (CNTA)’s Trailing Twelve Months Metrics - The Dwinnex
Centessa Pharmaceuticals executive sells over $260k in company stock - Investing.com India
Centessa Pharmaceuticals executive sells over $260k in company stock By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals plc ADR [CNTA] Shares Rise 2.15 % on Thursday - Knox Daily
Centessa Pharmaceuticals plc ADR (CNTA) is looking forward to a strong quarter - SETE News
Centessa's ORX142 shows promise for treating daytime sleepiness - Investing.com India
Monitoring Accenture plc (ACN) after recent insider movements - Knox Daily
ALLE stock rated an Underweight by Barclays - Knox Daily
Understanding the Risks of Investing in BranchOut Food Inc (BOF) - Knox Daily
EON Resources Inc. [EONR] Investment Guide: What You Need to Know - Knox Daily
Analysts review Reneo Pharmaceuticals Inc’s rating - Knox Daily
Analyzing Pineapple Energy Inc (PEGY) After Recent Trading Activity - Knox Daily
Investing in nVent Electric plc (NVT): What You Must Know - Knox Daily
Peraso Inc’s latest rating changes from various analysts - Knox Daily
Fiserv, Inc. [FI] Insider Bisignano Frank sells 145,000 Shares – Latest Insider Activity - Knox Daily
The Attractiveness of Investing In GE Aerospace (GE) is Growing - Knox Daily
President and CEO, MADER MARK PATRICK sold 20,000 shares of Smartsheet Inc [SMAR] - Knox Daily
Henry Schein Inc. [HSIC] Insider McGlynn Lorelei sells 21,035 Shares – McGlynn Lorelei Activity - Knox Daily
A Guide To The Risks Of Investing In Autodesk Inc. (ADSK) - Knox Daily
Is it a good time to sell Xcel Energy, Inc. [XEL] shares after an insider sold 2,041 shares? - Knox Daily
Chief Executive Officer, Scots-Knight Denise sold 60,046 shares of Mereo Biopharma Group Plc ADR [MREO] - Knox Daily
Verona Pharma Plc ADR [VRNA] President and CEO makes an insider sale of 600,000 shares worth $2.25 million. - Knox Daily
Recent Insider Activity Could Benefit Tractor Supply Co. (TSCO) - Knox Daily
Examining the Potential Price Growth of Biomarin Pharmaceutical Inc. (BMRN) - Knox Daily
The Potential Rise in the Price of Ventas Inc (VTR) following insiders activity - Knox Daily
Monitoring Ultragenyx Pharmaceutical Inc. (RARE) after recent insider movements - Knox Daily
Investing in Cannae Holdings Inc (CNNE): What You Must Know - Knox Daily
Analysts review Dyne Therapeutics Inc’s rating - Knox Daily
Citigroup analysts initates a Buy rating for Crinetics Pharmaceuticals Inc (CRNX) - Knox Daily
Texas Roadhouse Inc [TXRH] Insider Jones Wayne L. sells 700 Shares – Insider Selling Alert - Knox Daily
The Potential Rise in the Price of TransUnion (TRU) following insiders activity - Knox Daily
An Analysis of Trane Technologies plc (TT)’s Potential Price Growth - Knox Daily
OneMain Holdings Inc (OMF) gets rating Initiated from BTIG Research - Knox Daily
Chipotle Mexican Grill [CMG] Investment Appeal on the Rise - Knox Daily
Macrogenics Inc (MGNX) may enjoy gains as insiders got busy in the recent days - Knox Daily
Investing in CareTrust REIT Inc (CTRE) Is Getting More Attractive - Knox Daily
TD Cowen’s latest rating for KBR stock - Knox Daily
Upwork Inc (UPWK) Becoming More Attractive for Investors - Knox Daily
Investing in Trio Petroleum Corp. (TPET) Is Getting More Attractive - Knox Daily
Everi Holdings Inc (EVRI) gets rating Resumed from B. Riley Securities - Knox Daily
Recent Insider Activity Could Benefit Janus Henderson Group plc (JHG) - Knox Daily
JCI (Johnson Controls International plc) may reap gains as insiders became active recently - Knox Daily
Investing in Coursera Inc (COUR) Is Getting More Attractive - Knox Daily
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):